Crossmark

A feasibility study for in vivo treatment verification of IMRT using Monte Carlo dose calculation and deep learning-based modelling of EPID detector response

Crossref DOI link: https://doi.org/10.1186/s13014-022-01999-3

Published Online: 2022-02-10

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Jun https://orcid.org/0000-0002-9496-9845
Cheng, Zhibiao

Fan, Ziting

Zhang, Qilin

Zhang, Xile

Yang, Ruijie

Wen, Junhai
Funding

Funding for this research was provided by:

National Key R&D Program of China (2016YFC0105104)

NSAF (No. U1830126)

National Key Research and Development Program of China (2021YFE0202500)

Beijing Municipal Commission of science and technology collaborative innovation project (Z201100005620012)

Capital’s Funds for Health Improvement and Research (2020-2Z-40919)
License Information

Text and Data Mining valid from 2022-02-10

Version of Record valid from 2022-02-10
More Information

Article History

Received: 10 April 2021

Accepted: 30 January 2022

First Online: 10 February 2022

Declarations

:

: Not applicable.

: Not applicable.

: The authors have no relevant conflicts of interest to disclose.

Document is current

Any future updates will be listed below